New Zealand markets closed

Novartis AG (NVS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
84.92+0.25 (+0.30%)
At close: 4:00PM EDT
85.01 +0.09 (+0.11%)
After hours: 06:21PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5184.82B
Enterprise value 3215.31B
Trailing P/E 21.10
Forward P/E 112.27
PEG ratio (5-yr expected) 12.22
Price/sales (ttm)3.68
Price/book (mrq)3.45
Enterprise value/revenue 34.18
Enterprise value/EBITDA 711.81

Trading information

Stock price history

Beta (5Y monthly) 0.55
52-week change 30.88%
S&P500 52-week change 333.64%
52-week high 398.52
52-week low 377.04
50-day moving average 383.83
200-day moving average 388.79

Share statistics

Avg vol (3-month) 31.93M
Avg vol (10-day) 31.69M
Shares outstanding 52.24B
Implied shares outstanding 6N/A
Float 82.15B
% held by insiders 10.01%
% held by institutions 19.91%
Shares short (29 Sep 2021) 45.65M
Short ratio (29 Sep 2021) 42.76
Short % of float (29 Sep 2021) 4N/A
Short % of shares outstanding (29 Sep 2021) 40.25%
Shares short (prior month 30 Aug 2021) 44.8M

Dividends & splits

Forward annual dividend rate 43.2
Forward annual dividend yield 43.78%
Trailing annual dividend rate 33.40
Trailing annual dividend yield 34.02%
5-year average dividend yield 43.45
Payout ratio 480.99%
Dividend date 314 Mar 2021
Ex-dividend date 403 Mar 2021
Last split factor 21116:1000
Last split date 308 Apr 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin 17.43%
Operating margin (ttm)26.67%

Management effectiveness

Return on assets (ttm)6.94%
Return on equity (ttm)16.64%

Income statement

Revenue (ttm)51.56B
Revenue per share (ttm)22.81
Quarterly revenue growth (yoy)14.40%
Gross profit (ttm)35.5B
Net income avi to common (ttm)8.98B
Diluted EPS (ttm)3.95
Quarterly earnings growth (yoy)55.10%

Balance sheet

Total cash (mrq)5.31B
Total cash per share (mrq)2.38
Total debt (mrq)35.85B
Total debt/equity (mrq)66.22
Current ratio (mrq)0.80
Book value per share (mrq)24.16

Cash flow statement

Operating cash flow (ttm)13.42B
Levered free cash flow (ttm)11.74B